IDEXX Laboratories, Inc. (IDXX) Stock Overview
Explore IDEXX Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
IDEXX Laboratories, Inc. (IDXX)
Key Financials
Key Financials
Market Cap
55.4B
P/E Ratio
47.42
EPS (TTM)
$14.22
ROE
0.71%
IDXX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of IDEXX Laboratories, Inc. (NASDAQ: IDXX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IDEXX Laboratories, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IDXX on the NASDAQ shows an RSI of 72.29, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $643.27 for the NASDAQ listing.
Key metrics behind IDEXX Laboratories, Inc.'s NASDAQ-traded stock include a P/E ratio of 47.42 and a market capitalization of 55.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IDXX on the NASDAQ.